Global patent index - EP 1015635 A2

EP 1015635 A2 2000-07-05 - DETECTION OF MINIMAL RESIDUAL DISEASE IN LYMPHOID MALIGNANCIES

Title (en)

DETECTION OF MINIMAL RESIDUAL DISEASE IN LYMPHOID MALIGNANCIES

Title (de)

NACHWEIS VON MINIMALEN RESTERKRANKUNGEN BEI LYMPHOID-MALIGNITÄT

Title (fr)

DETECTION D'UNE PATHOLOGIE RESIDUELLE MINIME DANS DES TUMEURS MALIGNES LYMPHOIDES

Publication

EP 1015635 A2 (EN)

Application

EP 98944341 A

Priority

  • EP 98944341 A
  • EP 97202858 A
  • NL 9800542 W

Abstract (en)

[origin: WO9914366A2] The invention relates to the field of cancer diagnosis, more specific to the monitoring of disease development during and after treatment. The invention comprises a method for determining minimal residual disease comprising amplifying nucleic acid molecules using at least one primer reactive with a common gene segment and further comprising identifying malignancy-specific nucleic acid sequences by hybridising with a fluorogenic probe specifically and selectively reactive with said malignancy-specific nucleic acid sequences.

IPC 1-7 (main, further and additional classification)

C12Q 1/68

IPC 8 full level (invention and additional information)

C12Q 1/68 (2006.01)

CPC (invention and additional information)

C12Q 1/6886 (2013.01); C12Q 2600/118 (2013.01)

Citation (search report)

See references of WO 9914366A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9914366 A2 19990325; WO 9914366 A3 19990506; AU 9190098 A 19990405; CA 2303945 A1 19990325; EP 1015635 A2 20000705

INPADOC legal status

2002-10-09 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20020403

2000-08-09 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000417

2000-07-05 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE